Lv1
50 积分 2026-01-03 加入
1243P Pathologic response as early endpoint for survival following neoadjuvant therapy (NEO-AT) in resectable non-small cell lung cancer (rNSCLC): Systematic literature review and meta-analysis
6个月前
已关闭
Neoadjuvant approach for nonsmall cell lung cancer: overview of the current issues
6个月前
已完结
Adjuvant and Neoadjuvant Therapy in Non–Small-Cell Lung Cancer
6个月前
已完结
Efficacy and safety of neoadjuvant immunotherapy in resectable nonsmall cell lung cancer: A meta-analysis
7个月前
已完结
Bayesian network meta-analysis of efficacy and safety of neoadjuvant therapy for non-small-cell lung cancer
7个月前
已完结
OC-0062: An invidual data metaanalysis of phase II trials of adjuvant or induction chemotherapy for NSCLC treated with chemoRT
7个月前
已关闭
An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non–small cell lung cancer
7个月前
已完结
OC-0062: An invidual data metaanalysis of phase II trials of adjuvant or induction chemotherapy for NSCLC treated with chemoRT
7个月前
已完结
An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non–small cell lung cancer
7个月前
已完结
Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system review
7个月前
已完结
皖公网安备34019202002308
